Bausch Health Companies Inc. (TSX: BHC)
9.70
+0.16 (1.68%)
Jul 2, 2024, 4:00 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $8.97B USD in the twelve months ending March 31, 2024, with 10.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.15B USD with 10.75% year-over-year growth. In the year 2023, Bausch Health Companies had annual revenue of $8.76B USD with 7.79% growth.
Revenue (ttm)
$8.97B
Revenue Growth
+10.01%
P/S Ratio
0.29
Revenue / Employee
$442,329
Employees
20,270
Market Cap
3.56B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
Dec 31, 2016 | 9.67B | -824.80M | -7.86% |
Dec 31, 2015 | 10.50B | 2.24B | 27.05% |
Dec 31, 2014 | 8.26B | 2.49B | 43.22% |
Dec 31, 2013 | 5.77B | 2.22B | 62.68% |
Dec 31, 2012 | 3.55B | 1.08B | 43.97% |
Dec 31, 2011 | 2.46B | 1.28B | 108.55% |
Dec 31, 2010 | 1.18B | 360.81M | 43.98% |
Dec 31, 2009 | 820.43M | 63.25M | 8.35% |
Dec 31, 2008 | 757.18M | -85.64M | -10.16% |
Dec 31, 2007 | 842.82M | -227.66M | -21.27% |
Dec 31, 2006 | 1.07B | 134.94M | 14.42% |
Dec 31, 2005 | 935.54M | 48.99M | 5.53% |
Dec 31, 2004 | 886.54M | 62.82M | 7.63% |
Dec 31, 2003 | 823.72M | 35.70M | 4.53% |
Dec 31, 2002 | 788.03M | 204.76M | 35.11% |
Dec 31, 2001 | 583.26M | 274.09M | 88.65% |
Dec 31, 2000 | 309.17M | 132.67M | 75.17% |
Dec 31, 1999 | 176.50M | 63.70M | 56.47% |
Dec 31, 1998 | 112.80M | 30.40M | 36.89% |
Dec 31, 1997 | 82.40M | 16.00M | 24.10% |
Dec 31, 1996 | 66.40M | 45.80M | 222.33% |
Dec 31, 1995 | 20.60M | 3.30M | 19.08% |
Dec 31, 1994 | 17.30M | 6.20M | 55.86% |
Dec 31, 1993 | 11.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 5.91B |
Curaleaf Holdings, Inc. | 1.84B |
Tilray Brands, Inc. | 1.02B |
WELL Health Technologies Corp. | 838.19M |
Sienna Senior Living Inc. | 824.26M |
Canopy Growth Corporation | 329.61M |
Extendicare Inc. | 1.35B |
Knight Therapeutics Inc. | 332.21M |
Bausch Health Companies News
- 12 days ago - Bausch files patent suit against Norwich over generic Xifaxan - Seeking Alpha
- 12 days ago - Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals - Accesswire
- 18 days ago - Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences - Accesswire
- 4 weeks ago - Andrew Left of Citron Research Says 'The Prosecution of Trump Appears to Be Driven by Political Motives, Which Is Detrimental to Our Nation' - Benzinga
- 6 weeks ago - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 - Accesswire
- 6 weeks ago - Bausch Health Announces 2024 Annual Meeting of Shareholder Results - Accesswire
- 7 weeks ago - Bausch issues update on Xifaxan patent dispute with Norwich - Seeking Alpha
- 7 weeks ago - Bausch Health Announces Updates Related to Norwich XIFAXAN Matters - Accesswire